+
+
Stay Informed
SURGICAL VALVE SOLUTIONS

EPIC™ MAX
AORTIC STENTED TISSUE VALVE

Our latest aortic valve replacement solution for optimizing key clinical outcomes and the possibilities for patient lifetime management.

SURGICAL VALVE SOLUTIONS

EPIC™ MAX
AORTIC STENTED TISSUE VALVE

Our latest aortic valve replacement solution for optimizing key clinical outcomes and the possibilities for patient lifetime management.

OPTIMIZE OUTCOMES. 
REDEFINE POSSIBILITIES.

Epic™ Max is designed to refine the future of aortic valve replacement lifetime management by providing unparalleled hemodynamics* while maintaining the Epic Platform’s ease of implant, proven durability, and features designed for future intervention.

Maximize Today, Tomorrow, and The Road Ahead

The Epic Max valve demonstrates benefits experienced by both patients and surgeons:

  • Unparalleled Hemodynamics*
  • Ease of Implantation
  • Proven Long-Term Durability
  • Future Ready Valve-in-Valve** Features

 See 10-year Durability data from the Epic valve clinical data.

DOWNLOAD THE EPIC MAX BROCHURE

*Compared to previous Epic Platform iterations.
** The safety and effectiveness of valve-in-valve procedures in an Epic™ Max valve has not been established

Bioprosthetic Aortic Valve Replacement

The Epic Max valve is indicated for patients requiring replacement of a diseased, damaged, or malfunctioning native aortic valve. It may also be used as a replacement for a previously implanted aortic prosthetic heart valve.

Epic Max is an optimal solution for surgical aortic valve replacement and patient lifetime management. The larger redesigned internal orifice helps to alleviate the burden on the heart and reduce the load on the left ventricle. Having an index valve with a larger internal orifice area, low stent posts, and non-curtaining leaflets also has a positive effect on future valve-in-valve procedures. With the rise of transcatheter aortic valve replacement (TAVR) or transcatheter aortic valve implantation (TAVI) procedures, the Epic Max valve is a promising option for patients today, tomorrow, and the road ahead.

Returning to life's unlimited possibilities

Tom was diagnosed with mild aortic regurgitation in his 30s and started to experience extreme fatigue symptoms 20 years later. Tom received an Epic valve which opened a lifetime of opportunities for him. He regained his energy and reengaged in activities he loves most, like surfing.

Dana didn’t know she had a valve condition and was initially asymptomatic. Her general practitioner detected her heart murmur and recommended annual echocardiograms to keep an eye on it. Over time her symptoms progressed and impacted her active lifestyle. Dana was able to return to her favorite water activities after her aortic valve replacement with the Epic valve.

  • PORCINE LEAFLETS
  • LOW AORTIC PROTRUSION
  • UNIQUE PERICARDIAL SHIELD
  • LARGE STENT INTERNAL DIAMETER
  • ADAPTIVE CUFF

  • PORCINE LEAFLETS natural internally mounted leaflet tissue with maximal opening (no muscle bar), complete leaflet coaptation (no central gap), no leaflet curtaining, and less calcification with reduced risk for stroke during reintervention.1

  • LOW AORTIC PROTRUSION mitigates the risk of coronary obstruction and sinus jailing


    FLEXFIT™ POLYMER STENT

    • Fractures at 8 atm2
    • Eases implant
    • Accommodates minimally invasive surgery

  • UNIQUE PERICARDIAL SHIELD provides a tissue-to-tissue interface to help prevent the risk of abrasion

  • LARGE STENT INTERNAL DIAMETER expands treatment options for patients by facilitating valve-in-valve* procedures with a wide range of Transcatheter Aortic Valve Implantation prostheses

  • ADAPTIVE CUFF
    Engineered to:

    • Allow maximum flexibility and easy passage through all anatomies
    • Prevent paravalvular leaks by sealing in all planes and minimizes parachuting resistance when delivering the valve onto the annulus valve-in-valve*

EPIC™ SUPRA AORTIC STENTED TISSUE VALVE FEATURES

Epic Max
1
2
3
4
5

  1. PORCINE LEAFLETS

    Natural internally mounted leaflet tissue with maximal opening (no muscle bar), complete leaflet coaptation (no central gap), no leaflet curtaining, and less calcification with reduced risk for stroke during reintervention.1

  2. LOW AORTIC PROTRUSION

    Mitigates the risk of coronary obstruction and sinus jailing

    FLEXFITTMPOLYMER STENT

    • Fractures at 8 atm2
    • Eases implant
    • Accommodates minimally invasive surgery

  3. UNIQUE PERICARDIAL SHIELD

    Provides a tissue-to-tissue interface to help prevent the risk of abrasion

  4. LARGE STENT INTERNAL DIAMETER

    Expands treatment options for patients by facilitating valve-in-valve* procedures with a wide range of Transcatheter Aortic Valve Implantation prostheses

  5. ADAPTIVE CUFF

    Engineered to:

    • Allow maximum flexibility and easy passage through all anatomies
    • Prevent paravalvular leaks by sealing in all planes and minimizes parachuting resistance when delivering the valve onto the annulus valve-in-valve*
Epic Max Radiopacity at the stent posts and annulus

RADIOPAQUE MARKERS AT ANNULUS AND STENT POSTS enhances visibility for future valve-in-valve

*The safety and effectiveness of valve-in-valve procedures in an Epic™ Max valve has not been established

DOWNLOAD THE EPIC
MAX BROCHURE

Download now

SEE THE LATEST CLINICAL
DATA FOR EPIC PLATFORM

CLINICAL DATA

MAT-2307938 v3.0 | Item approved for U.S. use only.

References
  1. Keshishi, Melanie, et al. "Comparison of Modes of Failure and Clinical Outcomes Between Explanted Porcine and Bovine Pericardial Bioprosthetic Valves." Cardiovascular Pathology (2023): 107516.
  2. Allen, KB., Chhatriwalla, A., Cohen, DJ., et al.  Bioprosthetic valve fracture to facilitate transcatheter valve-in-valve implantation. Ann Thorac Surg. 2017;104:1501-1508.
Important Safety Information

Rx Only

EPIC™ MAX STENTED PORCINE TISSUE VALVES
INDICATIONS FOR USE

The Epic™ Max valve is indicated for patients requiring replacement of a diseased, damaged, or malfunctioning native aortic heart valve. It may also be used as a replacement for a previously implanted aortic prosthetic heart valve. 

CONTRAINDICATIONS

None known. 

POTENTIAL ADVERSE EVENTS

Adverse events potentially associated with the use of bioprosthetic heart valves (in alphabetical order) include: angina; cardiac arrhythmias; endocarditis; heart failure; hemolysis; hemolytic anemia; hemorrhage, anticoagulant/antiplatelet-related; leak, transvalvular or paravalvular; myocardial infarction; nonstructural dysfunction (entrapment by pannus or suture, inappropriate sizing or positioning, or other); prosthesis regurgitation; stroke; structural deterioration (calcification, leaflet tear, or other); thromboembolism; valve thrombosis. It is possible that these complications could lead to: reoperation; explantation; permanent disability; death. 

YOU ARE ABOUT TO ENTER AN ABBOTT COUNTRY OR REGION SPECIFIC WEBSITE.

Please be aware that the website you have requested is intended for the residents of a particular country or countries, as noted on that site. As a result, the site may contain information on pharmaceuticals, medical devices and other products or uses of the product that are not approved in other countries or regions.

U.S. VISITOR INTERNATIONAL VISITOR

YOU ARE ABOUT TO LEAVE
www.structural­heart.abbott

You are now leaving www.structuralheart.abbott. Abbott is not responsible for any content published on the third-party website you are about to enter. Abbott has not reviewed and does not endorse any information presented on third-party websites.

OkCancel
+